Clinical Study: International Identify Breast Cancer (IDBC) Study
Clinical studies are ongoing in Calgary, Canada, and Manchester, UK
Methodology
Through the ongoing IDBC international clinical study (NCT04495244), whole blood samples (2.5 ml) are being analyzed using Onco-ID Breast.
The participant group includes women aged 25 to 80 years with no breast surgery in the past year and no previous cancer diagnosis except non-melanoma skin cancer.
Blood samples are collected around the time of screening mammography and before any biopsies or surgeries.